Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor
Authors:
- 16 October 2018
- journal article
- research article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 43 (1) , 435-442
Abstract
Sleep disorder is confirmed as a core component of Alzheimer's disease (AD), while the accumulation of amyloid β (Aβ) in brain tissue is an important pathological feature of AD. However, how Aβ affects AD‑associated sleep disorder is not yet well understood. In the present study, experiments on animal and cell models were performed to detect the association between sleep disorder and Aβ. It was observed that Aβ25‑35 administration significantly decreased non‑rapid eye movement sleep, while it increased wakefulness in mice. In addition, reverse transcription‑quantitative polymerase chain reaction and western blot analysis revealed that the expression levels of tau, p‑tau, orexin A and orexin neurons express adenosine A1 receptor (A1R) were markedly upregulated in the brain tissue of AD mice compared with that in samples obtained from control mice. Furthermore, the in vitro study revealed that the expression levels of tau, p‑tau, orexin A and adenosine A1R were also significantly increased in human neuroblastoma SH‑SY5Y cells treated with Aβ25‑35 as compared with the control cells. In addition, the tau inhibitor TRx 0237 significantly reversed the promoting effects of Aβ25‑35 on tau, p‑tau, orexin A and adenosine A1R expression levels, and adenosine A1R or orexin A knockdown also inhibited tau and p‑tau expression levels mediated by Aβ25‑35 in AD. These results indicate that Aβ and tau may be considered as novel biomarkers of sleep disorder in AD pathology, and that they function by regulating the expression levels of orexin A and adenosine A1R.Keywords
This publication has 37 references indexed in Scilit:
- In Vivo Blood Glucose Quantification Using Raman SpectroscopyPLOS ONE, 2012
- Activation of the basal forebrain by the orexin/hypocretin neuronesActa Physiologica, 2010
- Role of adenosine A1 receptor in the perifornical–lateral hypothalamic area in sleep–wake regulation in ratsBrain Research, 2009
- Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake CycleScience, 2009
- Cortical Firing and Sleep HomeostasisNeuron, 2009
- Sleep disturbance in mild to moderate Alzheimer's diseaseSleep Medicine, 2005
- Alzheimer's disease: β‐Amyloid protein and tauJournal of Neuroscience Research, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Mechanisms of ß-Amyloid Neurotoxicity: Perspectives of PharmacotherapyReviews in the Neurosciences, 2000
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991